These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33530198)

  • 41. Efficacy of intravitreal hemocoagulase for control of bleeding in rabbit experimental model of vitrectomy.
    Kim SH; Lee HS; Kim IT; Jung BH; Cho JH; Kwak JS
    Jpn J Ophthalmol; 1993; 37(4):379-84. PubMed ID: 8145382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current perspective on fibrinogen concentrate in critical bleeding.
    Leal-Noval SR; Fernández Pacheco J; Casado Méndez M; Cuenca-Apolo D; Múñoz-Gómez M
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):761-778. PubMed ID: 32479129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
    Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinogen replacement therapy for congenital fibrinogen deficiency.
    Bornikova L; Peyvandi F; Allen G; Bernstein J; Manco-Johnson MJ
    J Thromb Haemost; 2011 Sep; 9(9):1687-704. PubMed ID: 21711446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary hemorrhage/hemoptysis in children.
    Godfrey S
    Pediatr Pulmonol; 2004 Jun; 37(6):476-84. PubMed ID: 15114547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of fibrinogen concentrates for treatment of critical perioperative hemorrhage.
    Koller T; Parera Ruiz A; Diaz-Ricart M; Gómez Caro AM
    Drugs Today (Barc); 2021 Mar; 57(3):219-239. PubMed ID: 33729219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Fibrinogen in Trauma-Induced Coagulopathy.
    Meizoso JP; Moore EE; Pieracci FM; Saberi RA; Ghasabyan A; Chandler J; Namias N; Sauaia A
    J Am Coll Surg; 2022 Apr; 234(4):465-473. PubMed ID: 35290265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraocular infusate with hemocoagulase for the control of bleeding during vitreous surgery.
    Lee HS; Kim SH; Kim IT
    Korean J Ophthalmol; 1989 Jun; 3(1):6-10. PubMed ID: 2795941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemostatic value of hemocoagulase in otorhinolaryngology].
    SACRISTAN ALONSO T; GOMEZ LOPEZ F
    Rev Clin Esp; 1960 Jan; 76():103-7. PubMed ID: 14440670
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrinogen: A Clinical Update on Liver Transplantation.
    Sabate A; Dalmau A
    Transplant Proc; 2015 Dec; 47(10):2925-8. PubMed ID: 26707315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro-Con Debate: Fibrinogen Concentrate or Cryoprecipitate for Treatment of Acquired Hypofibrinogenemia in Cardiac Surgical Patients.
    Hensley NB; Mazzeffi MA
    Anesth Analg; 2021 Jul; 133(1):19-28. PubMed ID: 34127586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of hypofibrinogenemia with batroxobin on rat Masugi nephritis.
    Tomita K; Muso E; Tamura T; Kawai C
    Jpn Circ J; 1982 Jun; 46(6):577-82. PubMed ID: 7045444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
    Cushing MM; Haas T; Karkouti K; Callum J
    Transfusion; 2020 Jun; 60 Suppl 3():S17-S23. PubMed ID: 32478877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention.
    Xu G; Liu X; Zhu W; Yin Q; Zhang R; Fan X
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):193-7. PubMed ID: 17287638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical hemocoagulase: A novel method for achieving hemostasis.
    Gupta S; Jangra RS; Gupta SS; Gakhar A
    J Am Acad Dermatol; 2020 Mar; 82(3):e81-e82. PubMed ID: 31408681
    [No Abstract]   [Full Text] [Related]  

  • 57. The effective control of a bleeding injury using a medical adhesive containing batroxobin.
    You KE; Koo MA; Lee DH; Kwon BJ; Lee MH; Hyon SH; Seomun Y; Kim JT; Park JC
    Biomed Mater; 2014 Apr; 9(2):025002. PubMed ID: 24487019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfusion of fibrinogen concentrate before dental extractions in patients with afibrinogenemia: a narrative review supported by a case report with a proposed treatment protocol.
    Czajkowska S; Rupa-Matysek J; Brzezińska J; Surdacka A; Gil L
    Blood Transfus; 2023 Mar; 21(2):168-175. PubMed ID: 35969135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional improvement of hemostatic dressing by addition of recombinant batroxobin.
    Seon GM; Lee MH; Kwon BJ; Kim MS; Koo MA; Kim D; Seomun Y; Kim JT; Park JC
    Acta Biomater; 2017 Jan; 48():175-185. PubMed ID: 27769944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.
    Downey LA; Andrews J; Hedlin H; Kamra K; McKenzie ED; Hanley FL; Williams GD; Guzzetta NA
    Anesth Analg; 2020 Mar; 130(3):740-751. PubMed ID: 31490252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.